Palvella Therapeutics PVLA Net margin

Net margin at other companies

Relay Therapeutics, Inc.RLAY

-2,763.6%-568pp

Viridian Therapeutics, Inc.VRDN

-544.1%-271pp

ANI PharmaceuticalsANIP

11.1%+10.0pp

Arcutis Biotherapeutics, Inc.ARQT

-13.9%-6.6pp

Zevra Therapeutics, Inc.ZVRA

42.8%+38.6pp

Eton Pharmaceuticals, Inc.ETON

-9.5%-2.7pp

FAQ

What is Palvella Therapeutics's net margin?

Palvella Therapeutics (PVLA) reported net margin of 71.7% in Q1 2024.

How has Palvella Therapeutics's net margin changed year-over-year?

Palvella Therapeutics's net margin increased by 129.2% year-over-year, from -245.5% to 71.7%.

What is the long-term trend for Palvella Therapeutics's net margin?

Over 3 years (2020 to 2023), Palvella Therapeutics's net margin has grown at a -29.9% compound annual growth rate (CAGR), from -127% to 43.7%.

What does net margin mean?

Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.